Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trialsJonathan Emberson, Werner Hacke, Kennedy R. Lees et al.|The Lancet|2014Cited by 2.7k
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined SourceHans‐Christoph Diener, Ḱazunori Toyoda, Ralph L. Sacco et al.|New England Journal of Medicine|2019Cited by 809
High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD)Isao Taguchi, Ryozo Nagai, Satoshi Iimuro et al.|Circulation|2018Cited by 242
Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trialḰazunori Toyoda, Naoko Kumagai, Shinichiro Uchiyama et al.|The Lancet Neurology|2019Cited by 216
Chronic Kidney Disease and Cerebrovascular DiseaseDearbhla Kelly, Manish M. Sood, Ḱazunori Toyoda et al.|Stroke|2021Cited by 142